Indomethacin treatment slows disease progression and enhances a Th1 response in susceptible BALB/c mice infected with Leishmania major.
Autor(a) principal: | |
---|---|
Data de Publicação: | 1999 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da FIOCRUZ (ARCA) |
Texto Completo: | https://www.arca.fiocruz.br/handle/icict/5651 |
Resumo: | Fundação Oswaldo Cruz. Centro de Pesquisas Gonçalo Moniz. Salvador, Bahia, Brasil |
id |
CRUZ_4ca64a0461ba8e7680dcd2d74cc0dc0f |
---|---|
oai_identifier_str |
oai:www.arca.fiocruz.br:icict/5651 |
network_acronym_str |
CRUZ |
network_name_str |
Repositório Institucional da FIOCRUZ (ARCA) |
repository_id_str |
2135 |
spelling |
Freitas, Luiz Antonio Rodrigues deMbow, M. LamineEstay, MonicaBleyenberg, Julie A.Titus, Richard G.2012-10-05T17:53:04Z2012-10-05T17:53:04Z1999FREITAS, Luiz Antonio Rodrigues de et al. Indomethacin treatment slows disease progression and enhances a Th1 response in susceptible BALB/c mice infected with Leishmania major. Parasite Immunology, v. 21, n. 5, p. 273-7, May 1999.0141-9838https://www.arca.fiocruz.br/handle/icict/5651engIndomethacin treatment slows disease progression and enhances a Th1 response in susceptible BALB/c mice infected with Leishmania major.info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleFundação Oswaldo Cruz. Centro de Pesquisas Gonçalo Moniz. Salvador, Bahia, BrasilCollege of Veterinary Medicine and Biomedical Sciences. Colorado State University. Fort Collins USACollege of Veterinary Medicine and Biomedical Sciences. Colorado State University. Fort Collins USACollege of Veterinary Medicine and Biomedical Sciences. Colorado State University. Fort Collins USACollege of Veterinary Medicine and Biomedical Sciences. Colorado State University. Fort Collins USAProstaglandins of the E series inhibit the development of Th1 responses. When infected with Leishmania major, BALB/c mice fail to develop a Th1 response, but instead mount a Th2 response and die of the disease. Therefore, we treated L. major-infected BALB/c mice with indomethacin, which inhibits prostaglandin production. Indomethacin lessened disease severity (parasite burden and pathology), and promoted a Th1 response, but the mice still succumbed to infection. The explanation for these observations may be two-fold: (1) the beneficial effects of indomethacin were predominantly observed later in infection (beyond two weeks), a time at which indomethacin was unable to sufficiently block the development of a Th2 response; (2) indomethacin was unable to induce a Th1 response in BALB/c mice that was of the same magnitude as the Th1 response observed in C57BL/6 mice infected with L. major.Leishmania MajorLeishmaniasisProstaglandinsCytokinesNitric OxideAntiprotozoários/uso terapêuticoIndometacina/uso terapêuticoLeishmania majorLeishmaniose Cutânea/quimioterapiaCélulas Th1/imunologiaAnimaisInibidores de Ciclooxigenase/uso terapêuticoProgressão da DoençaFemininoImunidade CelularLeishmaniose Cutânea/imunologiaCamundongosCamundongos Endogâmicos BALB CCamundongos Endogâmicos C57BLAntagonistas de Prostaglandina/uso terapêuticoinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZORIGINALdE Freitas LA Indomethacin treatment slows....pdfdE Freitas LA Indomethacin treatment slows....pdfapplication/pdf120581https://www.arca.fiocruz.br/bitstream/icict/5651/1/dE%20Freitas%20LA%20Indomethacin%20treatment%20slows....pdfc18d299d9b2068ca5c74e80986fe775aMD51LICENSElicense.txtlicense.txttext/plain; charset=utf-82008https://www.arca.fiocruz.br/bitstream/icict/5651/2/license.txt06db3f0df647fd9ddff657403bbe0ee2MD52TEXTdE Freitas LA Indomethacin treatment slows....pdf.txtdE Freitas LA Indomethacin treatment slows....pdf.txtExtracted texttext/plain23317https://www.arca.fiocruz.br/bitstream/icict/5651/5/dE%20Freitas%20LA%20Indomethacin%20treatment%20slows....pdf.txt0fdeddb191687f2c27f27249befce0ccMD55THUMBNAILdE Freitas LA Indomethacin treatment slows....pdf.jpgdE Freitas LA Indomethacin treatment slows....pdf.jpgGenerated Thumbnailimage/jpeg1885https://www.arca.fiocruz.br/bitstream/icict/5651/4/dE%20Freitas%20LA%20Indomethacin%20treatment%20slows....pdf.jpgd704a521e81a23d7752477586e3f753cMD54icict/56512023-03-15 14:33:10.571oai:www.arca.fiocruz.br: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Repositório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-03-15T17:33:10Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false |
dc.title.pt_BR.fl_str_mv |
Indomethacin treatment slows disease progression and enhances a Th1 response in susceptible BALB/c mice infected with Leishmania major. |
title |
Indomethacin treatment slows disease progression and enhances a Th1 response in susceptible BALB/c mice infected with Leishmania major. |
spellingShingle |
Indomethacin treatment slows disease progression and enhances a Th1 response in susceptible BALB/c mice infected with Leishmania major. Freitas, Luiz Antonio Rodrigues de Leishmania Major Leishmaniasis Prostaglandins Cytokines Nitric Oxide Antiprotozoários/uso terapêutico Indometacina/uso terapêutico Leishmania major Leishmaniose Cutânea/quimioterapia Células Th1/imunologia Animais Inibidores de Ciclooxigenase/uso terapêutico Progressão da Doença Feminino Imunidade Celular Leishmaniose Cutânea/imunologia Camundongos Camundongos Endogâmicos BALB C Camundongos Endogâmicos C57BL Antagonistas de Prostaglandina/uso terapêutico |
title_short |
Indomethacin treatment slows disease progression and enhances a Th1 response in susceptible BALB/c mice infected with Leishmania major. |
title_full |
Indomethacin treatment slows disease progression and enhances a Th1 response in susceptible BALB/c mice infected with Leishmania major. |
title_fullStr |
Indomethacin treatment slows disease progression and enhances a Th1 response in susceptible BALB/c mice infected with Leishmania major. |
title_full_unstemmed |
Indomethacin treatment slows disease progression and enhances a Th1 response in susceptible BALB/c mice infected with Leishmania major. |
title_sort |
Indomethacin treatment slows disease progression and enhances a Th1 response in susceptible BALB/c mice infected with Leishmania major. |
author |
Freitas, Luiz Antonio Rodrigues de |
author_facet |
Freitas, Luiz Antonio Rodrigues de Mbow, M. Lamine Estay, Monica Bleyenberg, Julie A. Titus, Richard G. |
author_role |
author |
author2 |
Mbow, M. Lamine Estay, Monica Bleyenberg, Julie A. Titus, Richard G. |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Freitas, Luiz Antonio Rodrigues de Mbow, M. Lamine Estay, Monica Bleyenberg, Julie A. Titus, Richard G. |
dc.subject.en.pt_BR.fl_str_mv |
Leishmania Major Leishmaniasis Prostaglandins Cytokines Nitric Oxide |
topic |
Leishmania Major Leishmaniasis Prostaglandins Cytokines Nitric Oxide Antiprotozoários/uso terapêutico Indometacina/uso terapêutico Leishmania major Leishmaniose Cutânea/quimioterapia Células Th1/imunologia Animais Inibidores de Ciclooxigenase/uso terapêutico Progressão da Doença Feminino Imunidade Celular Leishmaniose Cutânea/imunologia Camundongos Camundongos Endogâmicos BALB C Camundongos Endogâmicos C57BL Antagonistas de Prostaglandina/uso terapêutico |
dc.subject.decs.pt_BR.fl_str_mv |
Antiprotozoários/uso terapêutico Indometacina/uso terapêutico Leishmania major Leishmaniose Cutânea/quimioterapia Células Th1/imunologia Animais Inibidores de Ciclooxigenase/uso terapêutico Progressão da Doença Feminino Imunidade Celular Leishmaniose Cutânea/imunologia Camundongos Camundongos Endogâmicos BALB C Camundongos Endogâmicos C57BL Antagonistas de Prostaglandina/uso terapêutico |
description |
Fundação Oswaldo Cruz. Centro de Pesquisas Gonçalo Moniz. Salvador, Bahia, Brasil |
publishDate |
1999 |
dc.date.issued.fl_str_mv |
1999 |
dc.date.accessioned.fl_str_mv |
2012-10-05T17:53:04Z |
dc.date.available.fl_str_mv |
2012-10-05T17:53:04Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
FREITAS, Luiz Antonio Rodrigues de et al. Indomethacin treatment slows disease progression and enhances a Th1 response in susceptible BALB/c mice infected with Leishmania major. Parasite Immunology, v. 21, n. 5, p. 273-7, May 1999. |
dc.identifier.uri.fl_str_mv |
https://www.arca.fiocruz.br/handle/icict/5651 |
dc.identifier.issn.none.fl_str_mv |
0141-9838 |
identifier_str_mv |
FREITAS, Luiz Antonio Rodrigues de et al. Indomethacin treatment slows disease progression and enhances a Th1 response in susceptible BALB/c mice infected with Leishmania major. Parasite Immunology, v. 21, n. 5, p. 273-7, May 1999. 0141-9838 |
url |
https://www.arca.fiocruz.br/handle/icict/5651 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da FIOCRUZ (ARCA) instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
reponame_str |
Repositório Institucional da FIOCRUZ (ARCA) |
collection |
Repositório Institucional da FIOCRUZ (ARCA) |
bitstream.url.fl_str_mv |
https://www.arca.fiocruz.br/bitstream/icict/5651/1/dE%20Freitas%20LA%20Indomethacin%20treatment%20slows....pdf https://www.arca.fiocruz.br/bitstream/icict/5651/2/license.txt https://www.arca.fiocruz.br/bitstream/icict/5651/5/dE%20Freitas%20LA%20Indomethacin%20treatment%20slows....pdf.txt https://www.arca.fiocruz.br/bitstream/icict/5651/4/dE%20Freitas%20LA%20Indomethacin%20treatment%20slows....pdf.jpg |
bitstream.checksum.fl_str_mv |
c18d299d9b2068ca5c74e80986fe775a 06db3f0df647fd9ddff657403bbe0ee2 0fdeddb191687f2c27f27249befce0cc d704a521e81a23d7752477586e3f753c |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ) |
repository.mail.fl_str_mv |
repositorio.arca@fiocruz.br |
_version_ |
1813009077819670528 |